Semaglutide belongs to the GLP-1 receptor agonist class, while tirzepatide is a dual GIP/GLP-1 receptor agonist (incretin co-agonist)
Whether youre working with GLP-related compounds, peptide blends, or single compounds, our goal is to make sourcing simple and dependable
The goal is to become healthier, stronger, and metabolically more stable
Compounded medications from FDA-registered pharmacies provide the same therapeutic effects at a fraction of the cost
A New Era for Diabetes Care The NTU teams research reflects a broader shift towards precision medicine, tailoring treatments to each patients unique health profileconsidering factors like kidney function, cardiovascular risk, and overall health status
Phase three is full ketogenic transition after the final GLP-1 dose